Seeing Is Believing
Currently out of the existing stock ratings of Michael Schmidt, 104 are a BUY (73.76%), 37 are a HOLD (26.24%).
Analyst Michael Schmidt works at GUGGENHEIM with a stock forecast success ratio of 63.76% fulfilled within 311.41 days on average.
Michael Schmidt’s has documented 311 price targets and ratings displayed on 40 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MRSN, Mersana Therapeutics at 29-Feb-2024.
Analyst best performing recommendations are on IONS (IONIS PHARMACEUTICALS).
The best stock recommendation documented was for IONS (IONIS PHARMACEUTICALS) at 7/14/2016. The price target of $26 was fulfilled within 1 day with a profit of $1.48 (6.04%) receiving and performance score of 60.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1 years 10 months 9 days ago
0/10 (0%)
$4.56 (102.70%)
Hold
4.75
$4.66 (5177.78%)
5.75
2 years 5 months 20 days ago
10/12 (83.33%)
$0.06 (1.28%)
65
Sell
3 years 5 months 17 days ago
3/5 (60%)
$5.73 (134.19%)
42
Buy
16
$15.91 (17677.78%)
17
3 years 8 months 16 days ago
5/12 (41.67%)
$10.58 (195.20%)
77
Sell
4
$3.91 (4344.44%)
3
3 years 11 months 17 days ago
3/5 (60%)
$-4.07 (-50.43%)
191
Which stock is Michael Schmidt is most bullish on?
Which stock is Michael Schmidt is most reserved on?
What Year was the first public recommendation made by Michael Schmidt?